Costs

Significantly Higher Cost for T2DM Patients

Chart comparing cost of hospitalization and discharge for patients with type 2 diabetes vs. patients without. *All comparisons between cohorts are significant at P<0.001
T2DM patients (N=71,237)
Non-T2DM patients (N=244,970)
Please see the poster for demographic data.
  • Adjusted costs of index CV hospitalization and costs during the post-discharge period were significantly higher for patients with T2DM vs non-T2DM patients.

Incremental Burden of Type 2 Diabetes Mellitus in Patients Experiencing Cardiovascular Hospitalizations

Coutinho AD, Raju A, Wang W, et al.

High Proportion of Costs Incurred by T2DM Patients was for Treating CVD

Chart illustrating the high proportion of costs incurred by type 2 diabetes mellitus patients CVD - cardiovascular disease; T2DM - type 2 diabetes mellitus.
T2DM with CVD (N=138,384)
T2DM without CVD (N=639,960)
Please see the poster for demographic data.
  • Of the $11,829 mean total cost among all T2DM patients (CVD and non-CVD), 31.7% was associated with treating T2DM and its related complications. Of the $3,757, 28.3% were attributed to treating CVD.

Disproportionately High Direct Economic Burden of Type 2 Diabetes Mellitus in Patients With Comorbid Cardiovascular Disease

Sander SD, Lunacsek O, Stafkey-Mailey D, et al.

Over 6X Higher Cost for T2DM Patients with CVD

Over 6X Higher Cost for T2DM Patients with CVD *All comparisons between cohorts are significant at P<0.001
CVD - cardiovascular disease; T2DM - type 2 diabetes mellitus.
T2DM with CVD (N=138,384)
T2DM without CVD (N=639,960)
Please see the poster for demographic data.
  • Mean annual all-cause costs were 2.8 times higher in the CVD cohort compared to the non-CVD cohort. Inpatient costs were 6.3 times higher in the CVD cohort compared to the non-CVD cohort.

Disproportionately High Direct Economic Burden of Type 2 Diabetes Mellitus in Patients With Comorbid Cardiovascular Disease

Sander SD, Lunacsek O, Stafkey-Mailey D, et al.

Inpatient HF Cohort Drive Higher Post-Index Costs*

Number of All-cause Healthcare Visits, per Patient per Month by Setting of Care During the Post-index Period *All comparisons were statistically significant at P<0.001, with the exception of ER costs in the high risk cohort which was statistically significant at P=0.004
Other outpatient visits may include labs, diagnostics, home health, etc.
HF - heart failure; USD - United States dollars.
Low Risk: HF (n=5,128); Non-HF (n=5,128)
High Risk: HF (n=301); Non-HF (n=301)
Please see the poster for demographic data.
  • Inpatient costs accounted for the largest difference, and were 5.4 and 7.9 times higher in the HF cohort compared to the non-HF cohort among low- and high-risk patients, respectively.

The Economic Burden of Patients With Type 2 Diabetes Mellitus Hospitalized for Heart Failure

Stafkey-Mailey D, Fuldeore RM, Shetty S, et al.